Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 99881581

  Document Type - Tender Notices

Description - Description: Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for medicines dispensed at the expense of statutory health insurance companies. In view of the relev ant statutory provisions for the award of public contracts, DAK-Gesundheit carries out a regular process of active ingredient-related, formal award procedures in accordance with the provisions of Part 4 of the GWB. For medicines containing the above-mentioned active ingredient, aripiprazole (only dosage forms for the manufacture of a depot injection suspension), ATC N05AX12, which are to be specified by the bidder in Annex 2 to the contract, DAK-

Mt Ref Id - 99881581

Deadline - Dec 04, 2026